SSTR2 Antibodies

Santa Cruz Biotechnology offers a broad range of SSTR2 monoclonal antibodies for studying somatostatin receptor type 2. SSTR2 monoclonal antibodies are validated for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The somatostatin receptor type 2 plays a crucial role in regulating endocrine and exocrine secretions, as well as modulating neurotransmission and cell proliferation. SSTR2 is essential in various physiological processes, including the inhibition of hormone release and the regulation of cell growth. Current research highlights SSTR2's significance as a target in cancer research and neurobiology studies. Ongoing investigations continue to reveal new insights about SSTR2's functions in cellular signaling pathways and therapeutic applications. Understanding SSTR2's mechanisms has opened new avenues for developing targeted treatments in various medical conditions. Santa Cruz Biotechnology monoclonal antibodies for SSTR2 research contribute to advancing scientific knowledge and therapeutic discoveries in the research community.